These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36319569)

  • 1. Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis.
    Moshiree B; Freeman AJ; Vu PT; Khan U; Ufret-Vincenty C; Heltshe SL; Goss CH; Schwarzenberg SJ; Freedman SD; Borowitz D; Sathe M;
    J Cyst Fibros; 2023 Mar; 22(2):266-274. PubMed ID: 36319569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of electronic patient-reported outcome measures in cystic fibrosis research: Application to the GALAXY study.
    Sathe M; Moshiree B; Vu PT; Khan U; Heltshe SL; Romasco M; Freedman SD; Schwarzenberg SJ; Goss CH; Freeman AJ
    J Cyst Fibros; 2021 Jul; 20(4):605-611. PubMed ID: 34305007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI disorders.
    Hayee B; Watson KL; Campbell S; Simpson A; Farrell E; Hutchings P; Macedo P; Perrin F; Whelan K; Elston C
    United European Gastroenterol J; 2019 Aug; 7(7):881-888. PubMed ID: 31428412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI.
    Schwarzenberg SJ; Vu PT; Skalland M; Hoffman LR; Pope C; Gelfond D; Narkewicz MR; Nichols DP; Heltshe SL; Donaldson SH; Frederick CA; Kelly A; Pittman JE; Ratjen F; Rosenfeld M; Sagel SD; Solomon GM; Stalvey MS; Clancy JP; Rowe SM; Freedman SD;
    J Cyst Fibros; 2023 Mar; 22(2):282-289. PubMed ID: 36280527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing the GALAXY study: Partnering with the cystic fibrosis community to optimize assessment of gastrointestinal symptoms.
    Freeman AJ; Sathe M; Aliaj E; Borowitz D; Fogarty B; Goss CH; Freedman S; Heltshe SL; Khan U; Riva D; Roman C; Romasco M; Schwarzenberg SJ; Ufret-Vincenty CA; Moshiree B
    J Cyst Fibros; 2021 Jul; 20(4):598-604. PubMed ID: 33451899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes is associated with increased burden of gastrointestinal symptoms in adults with cystic fibrosis.
    Caley LR; Zagoya C; Duckstein F; White H; Shimmin D; Jones AM; Barrett J; Whitehouse JL; Floto RA; Mainz JG; Peckham DG
    J Cyst Fibros; 2023 Mar; 22(2):275-281. PubMed ID: 36710099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimating minimal clinically important difference (MCID) for gastrointestinal symptoms in cystic fibrosis.
    Lee M; Sathe M; Moshiree B; Vu PT; Heltshe SL; Schwarzenberg SJ; Freedman SD; Freeman AJ
    J Cyst Fibros; 2024 Sep; 23(5):991-999. PubMed ID: 39048465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How can we relieve gastrointestinal symptoms in people with cystic fibrosis? An international qualitative survey.
    Smith S; Rowbotham N; Davies G; Gathercole K; Collins SJ; Elliott Z; Herbert S; Allen L; Ng C; Smyth A
    BMJ Open Respir Res; 2020 Sep; 7(1):. PubMed ID: 32900780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constipation and DIOS: Diagnosis, differential diagnosis, and management.
    Saikumar P; Sadauskas M; Izhar S; Moshiree B; Patel D
    Pediatr Pulmonol; 2024 Sep; 59 Suppl 1():S81-S90. PubMed ID: 39105354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scoring Abdominal Symptoms in People with Cystic Fibrosis.
    Tabori H; Barucha A; Zagoya C; Duckstein F; Dunay GA; Sadrieh P; Polte L; Mainz JG
    J Clin Med; 2024 Mar; 13(6):. PubMed ID: 38541878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a mobile application for self-management of pancreatic enzyme replacement therapy is associated with improved gastro-intestinal related quality of life in children with Cystic Fibrosis.
    Boon M; Calvo-Lerma J; Claes I; Havermans T; Asseiceira I; Bulfamante A; Garriga M; Masip E; van Schijndel BAM; Fornes V; Barreto C; Colombo C; Crespo P; Vicente S; Janssens H; Hulst J; Witters P; Nobili R; Pereira L; Ruperto M; Van der Wiel E; Mainz JG; De Boeck K; Ribes-Koninckx C
    J Cyst Fibros; 2020 Jul; 19(4):562-568. PubMed ID: 32335023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validity and Reliability of a Novel Multimodal Questionnaire for the Assessment of Abdominal Symptoms in People with Cystic Fibrosis (CFAbd-Score).
    Jaudszus A; Zeman E; Jans T; Pfeifer E; Tabori H; Arnold C; Michl RK; Lorenz M; Beiersdorf N; Mainz JG
    Patient; 2019 Aug; 12(4):419-428. PubMed ID: 30887269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of endoscopy and biopsy in the management of severe gastrointestinal disease in cystic fibrosis patients.
    Shah N; Tan HL; Sebire N; Suri R; Leuven K
    Pediatr Pulmonol; 2013 Dec; 48(12):1181-9. PubMed ID: 23825099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lubiprostone vs Senna in postoperative orthopedic surgery patients with opioid-induced constipation: a double-blind, active-comparator trial.
    Marciniak CM; Toledo S; Lee J; Jesselson M; Bateman J; Grover B; Tierny J
    World J Gastroenterol; 2014 Nov; 20(43):16323-33. PubMed ID: 25473191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing gastro-intestinal related quality of life in cystic fibrosis: Validation of PedsQL GI in children and their parents.
    Boon M; Claes I; Havermans T; Fornés-Ferrer V; Calvo-Lerma J; Asseiceira I; Bulfamante A; Garriga M; Masip E; Woodcock S; Walet S; Barreto C; Colombo C; Crespo P; Van der Wiel E; Hulst J; Martinez-Barona S; Nobili R; Pereira L; Ruperto M; Vicente S; De Boeck K; Ribes-Koninckx C;
    PLoS One; 2019; 14(12):e0225004. PubMed ID: 31860639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsiveness and interpretation of a symptom severity index specific to upper gastrointestinal disorders.
    Revicki DA; Rentz AM; Tack J; Stanghellini V; Talley NJ; Kahrilas P; De La Loge C; Trudeau E; Dubois D
    Clin Gastroenterol Hepatol; 2004 Sep; 2(9):769-77. PubMed ID: 15354277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.
    Green J; Gilchrist FJ; Carroll W
    Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012619. PubMed ID: 29894558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.
    Carroll W; Green J; Gilchrist FJ
    Cochrane Database Syst Rev; 2021 Dec; 12(12):CD012619. PubMed ID: 34936085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study].
    Maev IV; Okhlobystina OZ; Khalif IL; Andreev DN
    Ter Arkh; 2023 Feb; 95(1):38-51. PubMed ID: 37167114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.